Location History:
- San Mateo, CA (US) (1986 - 1988)
- Piedmont, CA (US) (1986 - 2010)
Company Filing History:
8 out of 672 
5 out of 212 
2 out of 245 
Years Active: 1986-2010
Title: The Innovations of Abla A Creasey: Revolutionizing Treatment Approaches in Medicine
Introduction: Abla A Creasey, a brilliant inventor based in Piedmont, CA, has made significant contributions to the field of medicine with his groundbreaking patents and innovative treatment methods. With an impressive total of 17 patents to his name, Creasey has been at the forefront of developing novel approaches to combat severe pneumonia, sepsis, and inflammation.
Latest Patents: Creasey's recent patents showcase his dedication to improving patient care and outcomes. His patented method for the treatment of severe pneumonia involves the administration of tissue factor pathway inhibitor (TFPI) or a TFPI analog through continuous intravenous infusion. By utilizing low doses to mitigate adverse side effects, Creasey's method aims to provide effective and safer treatment options for patients.
Another noteworthy patent by Creasey is his method for using lipoprotein associated coagulation inhibitor (LACI) to treat sepsis and septic shock. This innovative approach not only addresses the critical condition of sepsis but also aids in managing inflammation in patients. Creasey's LACI, with its specific characteristics and amino acid composition, has shown remarkable efficacy in the treatment of sepsis-related conditions.
Career Highlights: Throughout his career, Abla A Creasey has lent his expertise to prominent companies in the medical research industry. He has made valuable contributions to the research and development endeavors at Chiron Corporation and Cetus Corporation, where his inventive spirit and dedication to advancing healthcare solutions have been widely recognized.
Collaborations: Collaborating with esteemed professionals in the field, Creasey has worked alongside notable individuals such as Michael A Innis and David F Mark. Together, they have synergized their talents and expertise to drive forward innovative projects and foster a culture of excellence in medical research.
Conclusion: Abla A Creasey's remarkable journey as an inventor underscores his commitment to improving healthcare practices and enhancing patient well-being. His pioneering work in developing novel treatment methods for severe conditions like pneumonia and sepsis has left an indelible mark on the medical landscape. Creasey's unwavering dedication to innovation continues to inspire future generations of inventors and researchers in the pursuit of transformative healthcare solutions.